(1) (a) is in a unit pack or the manufacturer's sealed container; or (b) is an injectable medication;

(a) is in a unit pack or the manufacturer's sealed container; or

(b) is an injectable medication;

(2) (a) is unopened; or (b) is a cancer drug packaged in an unopened single-unit dose that has been removed from a multi-dose package;

(a) is unopened; or

(b) is a cancer drug packaged in an unopened single-unit dose that has been removed from a multi-dose package;

(3) is accepted and dispensed by the eligible pharmacy before: (a) a beyond use date that appears on the label; (b) the expiration date recommended by the manufacturer; or (c) a date, established by division rule for a specific prescription drug, in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, that is later than the date in Subsection (3)(a) or (3)(b);

(a) a beyond use date that appears on the label;

(b) the expiration date recommended by the manufacturer; or

(c) a date, established by division rule for a specific prescription drug, in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, that is later than the date in Subsection (3)(a) or (3)(b);

(4) (a) is not adulterated or mislabeled; and (b) the pharmacist or licensed pharmacist technician accepting or dispensing the prescription drug does not have reason to believe that the prescription drug is adulterated or mislabeled.

(a) is not adulterated or mislabeled; and

(b) the pharmacist or licensed pharmacist technician accepting or dispensing the prescription drug does not have reason to believe that the prescription drug is adulterated or mislabeled.